316 results Brexit and data protection: preparing for a 'no-deal' As it stands, the UK will exit the European Union at midnight on 29 March 2019. Therefore, businesses within the UK, or with trade relations with the UK, would be best advised to assume that a no-deal Brexit is inevitable. The ACM follows EU approach in its first pharmaceutical merger The Dutch Authority for Consumers and Markets (ACM) recently reviewed its first merger between two pharmaceutical companies. Digitisation and competition law: past, present and future It is nearly time for the European Commission to reveal its course of action in digitisation and competition law. The need for speed in mergers is no reason to ignore rights of defence On 16 January 2019, the European Court of Justice clarified the procedural guarantees the European Commission needs to provide to merging parties during merger reviews. Wetsvoorstel tot implementatie Vierde Spoorwegpakket op 29 januari 2019 aangenomen Eerder schreven wij een blogbericht over de implementatie van het zogenaamde 'Vierde Spoorwegpakket'. In navolging van de Tweede Kamer (9 oktober 2018) heeft de Eerste Kamer het daartoe strekkende wetsvoorstel op 29 januari 2019 aangenomen. Loyalty rebate scheme 'saved' by pharma company's market misconceptions The UK Competition and Markets Authority (CMA) recently closed its investigation into a discount scheme by dominant pharma company Merck Sharp & Dohme (MSD) aimed at preventing the National Health Service (NHS) from switching to competing biosimilars. Don't take the ACM's digital inspection guidelines too literally The Dutch Authority for Consumers and Markets' (ACM) digital inspection guidelines should be on every company's reading list. However, they should not be taken too literally; at least according to the recent ruling from the Court of Appeal in The Hague. Fine liability in antitrust cases is closely scrutinised by Dutch courts A parent company can be held liable for a subsidiary's anti-competitive conduct if the parent has exercised decisive influence over the subsidiary, because the two are then considered a single undertaking. Tick-tock: no reset of the appeal clock for amending Commission decision The European Court of Justice recently upheld the General Court's order finding that metal production and recycling company Eco-Bat had submitted its appeal outside of the appeal term. European Court of Justice sets aside Portuguese rules time-barring a damages action The European Court of Justice recently confirmed that if the EU Damages Directive does not apply, it is up to national rules to enable claimants to effectively claim EU antitrust damages. Stibbe advises ABN AMRO Stibbe advises ABN AMRO on the sale of a majority stake in Stater to Infosys. Stibbe advises citizenM and its existing shareholders KRC and APG Stibbe advises citizenM hotels and its existing shareholders KRC and APG on an agreement whereby GIC, Singapore’s sovereign wealth fund, will acquire a 25% stake in citizenM valuing the company at €2 billion. European Parliament votes in favour of representative actions for consumers On 26 March 2019 the European Parliament approved an amended version of the European Commission's proposal for a Directive on representative actions for the protection of collective interests of consumers, following a debate on 25 March 2019. 15 aspects of Brexit you did not know A Brexit without a deal, or with a deal that does not cover all relevant aspects, is still a potential scenario. We have highlighted a number of unexpected legal consequences of Brexit in such a no deal or incomplete deal scenario. General Court leaves door ajar for pharma companies in the Servier-case On 12 December 2018, the General Court partly annulled the Commission's decision to fine drug manufacturer and originator company Servier and five generic companies in a reverse payment patent settlement case. Walking the tightrope between data protection and EU investigations Two recent publications confirm that it is possible for companies to cooperate with a European Commission investigation and still comply with the data protection rules. General Court dismisses Canal+ appeal against pay-TV commitment decision The General Court recently dismissed the appeal brought by Canal+ against the decision of the European Commission making the commitments of Paramount legally binding. Partial fine reduction for Deutsche Telekom and Slovak Telekom for abuse of dominance The General Court recently clarified that to establish a margin squeeze in the case of positive margins, the Commission needs to prove the exclusionary effects of the dominant company's pricing practices. Pagination Previous page Page 12 Current page 13 Page 14 Page 15 Next page
Brexit and data protection: preparing for a 'no-deal' As it stands, the UK will exit the European Union at midnight on 29 March 2019. Therefore, businesses within the UK, or with trade relations with the UK, would be best advised to assume that a no-deal Brexit is inevitable.
The ACM follows EU approach in its first pharmaceutical merger The Dutch Authority for Consumers and Markets (ACM) recently reviewed its first merger between two pharmaceutical companies.
Digitisation and competition law: past, present and future It is nearly time for the European Commission to reveal its course of action in digitisation and competition law.
The need for speed in mergers is no reason to ignore rights of defence On 16 January 2019, the European Court of Justice clarified the procedural guarantees the European Commission needs to provide to merging parties during merger reviews.
Wetsvoorstel tot implementatie Vierde Spoorwegpakket op 29 januari 2019 aangenomen Eerder schreven wij een blogbericht over de implementatie van het zogenaamde 'Vierde Spoorwegpakket'. In navolging van de Tweede Kamer (9 oktober 2018) heeft de Eerste Kamer het daartoe strekkende wetsvoorstel op 29 januari 2019 aangenomen.
Loyalty rebate scheme 'saved' by pharma company's market misconceptions The UK Competition and Markets Authority (CMA) recently closed its investigation into a discount scheme by dominant pharma company Merck Sharp & Dohme (MSD) aimed at preventing the National Health Service (NHS) from switching to competing biosimilars.
Don't take the ACM's digital inspection guidelines too literally The Dutch Authority for Consumers and Markets' (ACM) digital inspection guidelines should be on every company's reading list. However, they should not be taken too literally; at least according to the recent ruling from the Court of Appeal in The Hague.
Fine liability in antitrust cases is closely scrutinised by Dutch courts A parent company can be held liable for a subsidiary's anti-competitive conduct if the parent has exercised decisive influence over the subsidiary, because the two are then considered a single undertaking.
Tick-tock: no reset of the appeal clock for amending Commission decision The European Court of Justice recently upheld the General Court's order finding that metal production and recycling company Eco-Bat had submitted its appeal outside of the appeal term.
European Court of Justice sets aside Portuguese rules time-barring a damages action The European Court of Justice recently confirmed that if the EU Damages Directive does not apply, it is up to national rules to enable claimants to effectively claim EU antitrust damages.
Stibbe advises ABN AMRO Stibbe advises ABN AMRO on the sale of a majority stake in Stater to Infosys.
Stibbe advises citizenM and its existing shareholders KRC and APG Stibbe advises citizenM hotels and its existing shareholders KRC and APG on an agreement whereby GIC, Singapore’s sovereign wealth fund, will acquire a 25% stake in citizenM valuing the company at €2 billion.
European Parliament votes in favour of representative actions for consumers On 26 March 2019 the European Parliament approved an amended version of the European Commission's proposal for a Directive on representative actions for the protection of collective interests of consumers, following a debate on 25 March 2019.
15 aspects of Brexit you did not know A Brexit without a deal, or with a deal that does not cover all relevant aspects, is still a potential scenario. We have highlighted a number of unexpected legal consequences of Brexit in such a no deal or incomplete deal scenario.
General Court leaves door ajar for pharma companies in the Servier-case On 12 December 2018, the General Court partly annulled the Commission's decision to fine drug manufacturer and originator company Servier and five generic companies in a reverse payment patent settlement case.
Walking the tightrope between data protection and EU investigations Two recent publications confirm that it is possible for companies to cooperate with a European Commission investigation and still comply with the data protection rules.
General Court dismisses Canal+ appeal against pay-TV commitment decision The General Court recently dismissed the appeal brought by Canal+ against the decision of the European Commission making the commitments of Paramount legally binding.
Partial fine reduction for Deutsche Telekom and Slovak Telekom for abuse of dominance The General Court recently clarified that to establish a margin squeeze in the case of positive margins, the Commission needs to prove the exclusionary effects of the dominant company's pricing practices.